Sveriges mest populära poddar
Bloomberg Businessweek
NyheterNäringsliv

All Eyes on Gilead

18 min•15 maj 2020

Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. This is how Gilead Sciences prepared for the moment.

Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

See omnystudio.com/listener for privacy information.

Fler avsnitt av Bloomberg Businessweek

Visa alla avsnitt av Bloomberg Businessweek
Bloomberg Businessweek Weekend - August 28th, 2026
•37 min
Warsh Says Inflation Isn’t Slowing, Policymakers Will Bring it Down
•36 min
People Without Kids Are Hacking 529 Accounts for a Roth Backdoor
•8 min
Nvidia Fuels Bets on AI Trade
•42 min
The Mormon Church Is Quietly Expanding Its Real Estate Empire
•11 min
Nvidia’s Estimate-Topping Forecast Fails to Impress Investors
•42 min
VistaJet US President Leona Qi on Global Private Jet Expansion
•11 min
Bessent’s Mentor Stanley Druckenmiller Calls Bond Buying a Mistake
•41 min
Trump's Family Joins the Sprint to Get a National Bank Charter
•11 min
Bessent Warns Iran’s Trade Partners to Cut Ties or Face Sanctions
•42 min

Bloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.